Results 21 to 30 of about 1,599,346 (327)

Blastic plasmacytoid dendritic cell neoplasm: challenges and future prospects [PDF]

Blood and Lymphatic Cancer: Targets and Therapy, 2017
Amy M Trottier, Sonia Cerquozzi, Carolyn J Owen Division of Hematology and Hematological Malignancies, University of Calgary, Foothills Medical Centre, Calgary, AB, Canada Abstract: Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare CD4+ CD56+
Trottier AM, Cerquozzi S, Owen CJ
doaj   +1 more source

Blastic Plasmacytoid Dendritic Cell Neoplasm: From Origin of the Cell to Targeted Therapies. [PDF]

Biology of Blood and Marrow Transplantation, 2016
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematological malignancy with an aggressive clinical course. It is grouped with acute myeloid leukemia-related precursor neoplasms in the 2008 World Health Organization classification.
K. Laribi, N. Denizon, A. Besançon, J. Farhi, P. Lemaire, J. Sandrini, Catherine Truong, H. Ghnaya, Alix Baugier de Materre   +8 more
semanticscholar   +2 more sources

A Case of Blastic Plasmacytoid Dendritic Cell Neoplasm Extensively Studied by Flow Cytometry and Immunohistochemistry [PDF]

Case Reports in Hematology, 2017
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic malignancy with aggressive clinical course and poor prognosis. Diagnosis is based on detection of CD4+ CD56+, CD123high, TCL-1+, and blood dendritic cell antigen-2/CD303+ blasts ...
Martina Pennisi, Clara Cesana, Micol Giulia Cittone, Laura Bandiera, Barbara Scarpati, Valentina Mancini, Silvia Soriani, Silvio Veronese, Mauro Truini, Silvano Rossini, Roberto Cairoli   +10 more
doaj   +2 more sources

Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow Transplantation. [PDF]

Blood, 2011
Patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN) have a poor prognosis with conventional chemotherapy. In the present study, we retrospectively analyzed the outcome of patients with BPDCN who underwent allogeneic stem cell ...
D. Roos-Weil, S. Dietrich, A. Boumendil, E. Polge, D. Bron, E. Carreras, A. Iriondo Atienza, W. Arcese, D. Beelen, J. Cornelissen, N. Kröger, G. Milone, G. Rossi, F. Jardin, C. Peters, V. Rocha, A. Sureda, M. Mohty, P. Dreger   +18 more
semanticscholar   +2 more sources

Intestinal Autotransplantation and In-Situ Resection of Recurrent Pancreatic Head Intraductal Tubulopapillary Neoplasm with Portal Cavernoma: A Case Report [PDF]

, 2021
•Intraductal tubulopapillary neoplasm is a rare premalignant pancreatic neoplasia.•Frequently the proximity of the tumor to the large abdominal vessels precludes conventional resection.•Autotransplantation offers a safe and curative resection of ...
Vianna, Rodrigo, Nicolau-Raducu, Ramona, Raveh, Yehuda, Tekin, Akin, Selvaggi, Gennaro, Beduschi, Thiago, Hosein, Peter J   +6 more
core   +1 more source

Extramedullary relapse of Immunoglobulin A-kappa myeloma manifesting as plasmacytoma of the pleura without bone marrow involvement and following autologous bone marrow transplant: a case report

Journal of Medical Case Reports, 2023
Background Recurrence of multiple myeloma is among the most challenging issues for patients and treating physicians reported after autologous stem cell transplantation.
Alireza Rezvani, Reza Shahriarirad, Mohammad Javad Fallahi, Ali Zeighami   +3 more
doaj   +1 more source

Malignant neoplasms following cardiac transplantation [PDF]

European Journal of Cardio-Thoracic Surgery, 1997
Malignancies have long been recognized as a complication of long lasting immunosuppressive therapy. We reviewed our experience to investigate the incidence and the spectrum of non cutaneous de novo malignant neoplasms.Between March 1987 and March 1996, 296 patients underwent 303 cardiac transplantation in our service. The population at risk consists of
A, Curtil, J, Robin, F, Tronc, J, Ninet, P, Boissonnat, G, Champsaur   +5 more
openaire   +2 more sources

Blastic plasmacytoid dendritic cell neoplasm: a comprehensive review in pediatrics, adolescents, and young adults (AYA) and an update of novel therapies.

Leukemia, 2023
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic malignancy that can involve the bone marrow, peripheral blood, skin, lymph nodes, and the central nervous system.
Branko Cuglievan, Jeremy Connors, Jiasen He, S. Khazal, Sireesha Yedururi, J. Dai, S. Garcés, Andrés E Quesada, Michael Roth, Miriam Garcia, D. McCall, Amber Gibson, D. Ragoonanan, D. Petropoulos, P. Tewari, C. Nunez, K. Mahadeo, S. Tasian, A. Lamble, A. Pawlowska, D. Hammond, A. Maiti, F. Haddad, J. Senapati, Naval G. Daver, N. Gangat, M. Konopleva, S. Meshinchi, N. Pemmaraju   +28 more
semanticscholar   +1 more source

Haploidentical transplant with posttransplant cyclophosphamide vs matched related and unrelated donor transplant in acute myeloid leukemia and myelodysplastic neoplasm

Bone Marrow Transplantation, 2023
Hematopoietic cell transplantation from haploidentical donors (haploHCT) has facilitated treatment of AML and MDS by increasing donor availability and became more feasible since the introduction of post-transplant cyclophosphamide (ptCY).
Max J. Rieger, S. Stolz, A. Müller, R. Schwotzer, G. Nair, D. Schneidawind, M. Manz, U. Schanz   +7 more
semanticscholar   +1 more source

Favorable outcome of a patient with an unclassifiable myelodysplastic syndrome/myeloproliferative neoplasm treated with allogeneic hematopoietic stem cell transplantation

SAGE Open Medical Case Reports, 2021
The entity myelodysplastic syndrome/myeloproliferative neoplasm overlap syndrome is characterized by the coexistence of both myeloproliferative and myelodysplastic features in the bone marrow.
Anette Lodvir Hemsing, Bjørn Tore Gjertsen, Signe Spetalen, Lars Helgeland, Håkon Reikvam   +4 more
doaj   +1 more source